Niagen Bioscience Inc (NAGE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 16,697 | 18,812 | 22,616 | 45,389 | 1,642 |
| Receivables | 2,694 | 2,175 | 5,036 | 5,338 | 5,852 |
| Inventories | 11,683 | 11,535 | 8,249 | 5,796 | 7,913 |
| Other current assets | 0 | 0 | 56 | 0 | 18 |
| TOTAL | $32,219 | $33,518 | $36,534 | $57,178 | $15,737 |
| Non-Current Assets | |||||
| PPE Net | 3,206 | 3,765 | 3,585 | 2,872 | 1,778 |
| Investments And Advances | 0 | 0 | 0 | 0 | 20 |
| Intangibles | 1,082 | 1,311 | 1,547 | 1,652 | 486 |
| Other Non-Current Assets | 1,851 | 1,653 | 566 | 1,022 | 1,730 |
| TOTAL | $6,139 | $6,729 | $5,698 | $5,546 | $4,015 |
| Total Assets | $38,358 | $40,247 | $42,232 | $62,724 | $19,752 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,445 | 9,626 | 9,548 | 3,719 | 5,978 |
| Accrued Expenses | 6,133 | 4,415 | 4,444 | 3,645 | 2,170 |
| Other current liabilities | 278 | 169 | 275 | 414 | 389 |
| TOTAL | $16,476 | $15,063 | $14,440 | $8,088 | $8,869 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | 114 | 76 |
| Other Non-Current Liabilities | 997 | 848 | 0 | 0 | 185 |
| TOTAL | $5,458 | $4,739 | $614 | $802 | $909 |
| Total Liabilities | $21,934 | $19,802 | $15,054 | $8,890 | $9,778 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 66,739 | 59,788 | 55,286 | 54,836 | 37,908 |
| Common Shares | 62 | 60 | 55 | 55 | 38 |
| Retained earnings | -141,825 | -121,900 | -89,753 | -56,601 | -45,224 |
| Other shareholders' equity | -3 | 0 | 0 | 0 | 0 |
| TOTAL | $16,424 | $20,445 | $27,178 | $53,834 | $9,974 |
| Total Liabilities And Equity | $38,358 | $40,247 | $42,232 | $62,724 | $19,752 |